Development and longevity of antibodies against SARS‐CoV‐2 in kidney transplant recipients after symptomatic COVID‐19.
Autor: | Bajpai, Divya1 (AUTHOR) divyaa24@gmail.com, Shah, Deepal2 (AUTHOR), Bose, Sreyashi1 (AUTHOR), Deb, Satarupa1 (AUTHOR), Gandhi, Chintan1 (AUTHOR), Modi, Tulsi1 (AUTHOR), Rao, Nikhil1 (AUTHOR), Kumar, Kruteesh1 (AUTHOR), Saxena, Nikhil1 (AUTHOR), Katyal, Abhinav1 (AUTHOR), Patil, Ankita1 (AUTHOR), Thakare, Sayali1 (AUTHOR), Pajai, Atim E.1 (AUTHOR), Nataraj, Gita2 (AUTHOR), Jamale, Tukaram E.1 (AUTHOR) |
---|---|
Zdroj: | Transplant Infectious Disease. Aug2021, Vol. 23 Issue 4, p1-2. 2p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |